Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Ivonescimab for Treating Relapsed Pleural Mesothelioma in Patients After Immunotherapy and Chemotherapy

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Neoadjuvant Chemotherapy and Immunotherapy with Ipilimumab, Pemetrexed, and Drug Combination for Patients with Inoperable Pleural Mesothelioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium
  • Study on Atezolizumab for Patients with Malignant Pleural Mesothelioma After Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study of Tremelimumab for Patients with Unresectable Malignant Mesothelioma

    Recruiting

    2 1
    Investigated Drugs:
    Italy
  • Study of Intrapleural Photodynamic Therapy with Aminolevulinic Acid Hydrochloride and Nivolumab for Patients with Malignant Pleural Mesothelioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • Study on Adding Atezolizumab and WT1/DC Vaccine to Standard Treatment for Patients with Epithelioid Malignant Pleural Mesothelioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium
  • Study on Talazoparib for Maintenance Treatment in Patients with Advanced Malignant Pleural or Peritoneal Mesothelioma After Initial Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France
  • Study of Pembrolizumab with Cisplatin or Carboplatin and Pemetrexed for Patients with Resectable Malignant Pleural Mesothelioma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Italy
  • Study of WT1 LAMP mRNA DC Vaccine for Patients with Malignant Pleural Mesothelioma

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium
  • Study of Nivolumab, Ipilimumab, and UV1 Vaccine for Patients with Malignant Pleural Mesothelioma After Initial Chemotherapy

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Denmark Norway Spain Sweden